NeuroPace
Provides implanted brain-responsive stimulation and data tools for adults with drug-resistant focal epilepsy.
$14.41
After-hours close−0.00 (−0.03%)
At close$14.42(+2.02%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.11 | — | — |
| Aug 2026 | −$0.22 | −$0.18 | +17.4% |
| May 2026 | −$0.19 | −$0.13 | +31.6% |
| Mar 2026 | −$0.14 | −$0.08 | +42.9% |
| Nov 2025 | −$0.20 | −$0.11 | +45.0% |
The latest year is open to everyone — the 22 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| Jun 2021 | |||
| Mar 2021 | |||
| Dec 2020 | |||
| Jun 2020 | |||
| Mar 2020 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 3, 2026 | −$0.11 | — | — | $27.1M | — | — |
| Aug 11, 2026 | −$0.22 | −$0.18 | +17.4% | $22.6M | $22.8M | +0.9% |
| May 12, 2026 | −$0.19 | −$0.13 | +31.6% | $21.6M | $22.0M | +1.6% |
| Mar 3, 2026 | −$0.14 | −$0.08 | +42.9% | $24.7M | $26.6M | +7.4% |
| Nov 4, 2025 | −$0.20 | −$0.11 | +45.0% | $25.0M | $27.4M | +9.3% |
The latest year is open to everyone — the 22 quarters behind it read with an account. Sign in | ||||||
| Aug 12, 2025 | ||||||
| May 13, 2025 | ||||||
| Mar 4, 2025 | ||||||
| Nov 12, 2024 | ||||||
| Aug 13, 2024 | ||||||
| May 8, 2024 | ||||||
| Mar 5, 2024 | ||||||
| Nov 6, 2023 | ||||||
| Aug 8, 2023 | ||||||
| May 4, 2023 | ||||||
| Mar 2, 2023 | ||||||
| Nov 8, 2022 | ||||||
| Aug 11, 2022 | ||||||
| May 12, 2022 | ||||||
| Mar 10, 2022 | ||||||
| Nov 10, 2021 | ||||||
| Aug 12, 2021 | ||||||
| Jun 3, 2021 | ||||||
| Mar 24, 2021 | ||||||
| Dec 31, 2020 | ||||||
| Jun 30, 2020 | ||||||
| Mar 31, 2020 | ||||||